Buscar
Mostrando ítems 1-10 de 261
Assessment of the Effect of Triton X-114 on the Physicochemical Properties of an Antibody Fragment
(American Chemical Society, 2014-05)
The effect of Triton X-114 on the physicochemical properties of a single-chain antibody fragment (scFv) has been studied. According to the far UV circular dichroism spectroscopy, the secondary structure of the recombinant ...
Single-chain antibody fragments: Purification methodologies
(Elsevier, 2013-06)
At present, single-chain variable fragments (scFv) of antibodies are considered one of the most important tools in human therapies. Wide applications of antibodies are being exploited in different medical, pharmaceutical ...
F(ab')2 antibody fragments against Trypanosoma cruzi calreticulin inhibit its interaction with the first component of human complement
(Sociedad de Biología de Chile, 2005)
Cultivation of Pichia pastoris carrying the scFv anti LDL (−) antibody fragment. Effect of preculture carbon source
(Sociedade Brasileira de Microbiologia, 2017-07)
Antibodies and antibody fragments are nowadays among the most important biotechnological products, and Pichia pastoris is one of the most important vectors to produce them as well as other recombinant proteins. The conditions ...
F(ab')2 antibody fragments against Trypanosoma cruzi calreticulin inhibit its interaction with the first component of human complement
(Society of Biology of Chile, 2005)
Trypanosoma cruzi calreticulin (TcCRT), described in our laboratory, retains several important functional features from its vertebrate homologues. We have shown that recombinant TcCRT inhibits the human complement system ...
F(ab )2 antibody fragments against trypanosoma cruzi calreticulin inhibit its interaction with the first component of human complement
(SOCIEDAD DE BIOLOGIA DE CHILE, 2005)
F(ab)(2) antibody fragments against trypanosoma cruzi calreticulin inhibit its interaction with the first component of human complement
(SOCIEDAD DE BIOLOGIA DE CHILE, 2005)
Single-domain antibodies and the promise of modular targeting in cancer imaging and treatment
(Frontiers Research Foundation, 2018-02)
Monoclonal antibodies and their fragments have significantly changed the outcome of cancer in the clinic, effectively inhibiting tumor cell proliferation, triggering antibody-dependent immune effector cell activation and ...